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Introduction
Development of the vertebrate skeleton ensues with the aggre-
gation of mesenchymal cells into condensations. In endochon-
dral ossifi  cation, these precartilaginous condensations prefi  gure 
the elements of the adult skeleton, and alterations in this 
  program lead to a range of congenital skeletal abnormalities. 
  Various members of the transforming growth factor-β family 
fi  gure prominently at multiple stages within the skeletogenic 
program. Consequently, mutation or disruption of these genes 
or their receptors negatively impacts growth and development 
of the skeleton (Kingsley, 2001; Yoon et al., 2005). In particular, 
many of the bone morphogenetic proteins (BMPs) and growth 
and differentiation factors (GDFs) exhibit potent prochondro-
genic activity. Indeed, several of the BMPs have been shown to 
stimulate ectopic cartilage formation both in vivo and in vitro, 
whereas disruption of Noggin, which is a BMP antagonist 
(of BMP2, -4, and, to a lesser extent, -7), leads to skeletal over-
growth (Brunet et al., 1998). Thus, it appears that BMPs may 
promote the expansion of cartilage, either by stimulating the 
proliferation of chondroprogenitors or chondroblasts, or by 
  recruitment of cells with limited or no chondrogenic potential 
(Hall and Miyake, 2000). Downstream effectors of the BMP 
signaling cascade have been well characterized; however, the 
targets (direct and indirect) that underlie BMP action in chon-
drogenesis remain elusive.
Other signaling molecules that infl  uence the chondrogenic 
program include vitamin A and its metabolites, the retinoids 
(Weston et al., 2003a,b). The retinoids act through the modula-
tion of the transcriptional activity of the nuclear receptors for 
retinoic acid (RA), the RA receptors (RARs), and the retinoid X 
receptors. The transcriptional activity of these receptors is gov-
erned by RA availability, which is regulated largely by the com-
bined actions of the enzymes involved in its synthesis and 
degradation, the ALDH1As and CYP26s, respectively. Indeed, 
the Rars, and other genes encoding enzymes involved in RA 
metabolism, are dynamically expressed during chondrogenesis. 
Furthermore, compound null mutants of the Rars and null 
 mutants  of  Aldh2a1, Cyp26a1, or b1 present with a spectrum of 
skeletal abnormalities (Lohnes et al., 1994; Abu-Abed et al., 
2001; Niederreither et al., 2002b; Weston et al., 2003b; Yashiro 
et al., 2004). The formation of precartilaginous condensations 
and the subsequent appearance of chondroblasts require the 
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T
he bone morphogenetic protein (BMP) and growth 
and differentiation factor (GDF) signaling pathways 
have well-established and essential roles within 
the developing skeleton in coordinating the formation 
of   cartilaginous anlagen. However, the identiﬁ   cation 
of bona ﬁ  de targets that underlie the action of these 
  signaling   molecules in chondrogenesis has remained 
  elusive. We have identiﬁ  ed the gene for the retinoic acid 
(RA)   synthesis enzyme Aldh1a2 as a principal target of 
BMP signaling; prochondrogenic BMPs or GDFs lead to 
  attenuation of   Aldh1a2 expression and, consequently, to 
reduced   activation of the retinoid signaling pathway. 
Consistent with this, antagonism of retinoid signaling 
  phenocopies BMP4 action, whereas RA inhibits the 
  chondrogenic stimulatory activity of BMP4. BMP4 also 
down-regulates Aldh1a2 expression in organ culture and, 
consistent with this, Aldh1a2 is actively excluded from the 
developing cartilage anlagens. Collectively, these ﬁ  ndings 
provide novel insights into BMP action and demonstrate 
that BMP signaling governs the fate of prechondrogenic 
mesenchyme, at least in part, through regulation of 
  retinoid signaling.
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 activity  of  Sox9, which is a transcription factor belonging to the 
Sry-related HMG box gene family (Bi et al., 1999; Akiyama 
et al., 2002). In accordance with a proposed role for RA signaling 
in chondrogenesis, RA infl   uences the expression and/or 
 activity  of  Sox9 (Weston et al., 2000, 2002).
In earlier studies, we demonstrated that mesenchymal 
cells isolated from a transgenic animal overexpressing a weak, 
constitutively active Rara transgene exhibit skeletal defects, 
and this, in part, results from delayed or inhibited chondroblast 
differentiation (Cash et al., 1997). Subsequent studies have 
  indicated that the chondrogenic defect within the transgene 
mesenchyme is not rescued by the addition of BMP2 or -4, 
leading to the postulation that retinoid signaling may operate 
downstream of the BMP signaling pathway within this pro-
gram (Cash et al., 1997; Weston et al., 2000). Further series of 
experiments demonstrated that skeletal progenitor differentia-
tion requires RAR-mediated repression, and that antagonism 
of RAR signaling in primary cultures of limb mesenchyme is 
accompanied by increased Sox9 expression and activity 
(Weston et al., 2002). In this study, we demonstrate that BMPs 
decrease RA availability, and that this is required for their 
  prochondrogenic function. Furthermore, during autopod devel-
opment,  Aldh1a2 expression is dynamically expressed and 
 infl  uenced by BMP signaling. During this process, Aldh1a2 
expression becomes progressively restricted to nonchondro-
genic regions, where it likely serves to inhibit or suppress 
  expression of a chondroblast phenotype.
Results
To effectively model the chondrogenic program, we have 
used high-density primary cultures derived from the mesen-
chyme of embryonic age (E) 11.5 murine limb buds. For these 
purposes, two culture models have been used: (1) whole-limb 
(WL) cultures, which give rise to numerous cartilage nodules 
within 4 d (Fig. 1, A and B), and (2) distal tip (Tp) cultures, 
which contain a more homogenous chondroprogenitor popu-
lation and, thus, produce a much greater number of cartilage 
nodules (Fig. 1 B; Gay and Kosher, 1984). Consistent with 
this, Tp cultures exhibit a higher level of Sox9 expression 
(not depicted) and increased basal SOX9 activity (Fig. 1 E), 
relative to WL cultures. In accordance with previous studies, 
the addition of BMP4 to either of these cultures results in 
an increase in cartilage formation both in WL and Tp cultures 
and in limb-bud organotypic cultures (Fig. 1, B and C). 
  Accordingly, treatment with 10 ng/ml of exogenous BMP4 
leads to a more than twofold increase in Sox9 expression in 
both Tp cultures and WL cultures (Fig. 1 D; not depicted). 
Moreover, the addition of BMP4 generates a dose-dependent 
increase in endogenous SOX9 activity, as measured with 
a SOX9-responsive reporter gene (Fig. 1 E).
Expression proﬁ  ling of BMP action reveals 
the retinoid pathway as a central target
To better understand the mechanisms underlying BMP action, 
we used transcriptional profi  ling with Affymetrix U74 v2 chips 
A and B to identify genes in Tp cultures whose patterns of ex-
pression change in response to BMP4. Tp cultures were chosen 
for these analyses, as they are more homogenous and lack myo-
genic progenitors (Gay and Kosher, 1984; Weston et al., 2003c). 
Initially, the array data was fi  ltered to identify genes that  exhibit 
at least a fourfold change in expression between any of the 
treatment groups, generating a list of 364 genes (Fig. 2 A). 
  Further inspection of this group revealed that, with progressive 
culture time and/or the addition of BMP4, the expression of 
several cartilage ECM genes (Fig. 2, A and B, blue) and tran-
scription factors with proscribed roles in chondrogenesis, such 
as Sox5, 6, and 9, and Dlx5 (Fig. 2, A and B; Smits et al., 2001; 
Robledo et al., 2002), increases signifi  cantly. Importantly, these 
trends in gene expression are consistent with expression of the 
chondroblast phenotype. To identify those genes that were spe-
cifi  cally up- or down-regulated in response to BMP4, individual 
time points with and without treatment were analyzed and a 
stringent fourfold expression change cutoff was once again 
used. Genes from the 24- and 72-h time points were pooled, 
  resulting in a list of 41 genes, 4 of which (Aldh1a2, Rbp1, Nog, 
Figure 1.  Exogenous BMP4 increases carti-
lage formation, up-regulates endogenous 
Sox9 expression, and increases SOX9 activity. 
(A) Schematic representation of the regions 
used from E11.5 murine limbs to generate WL 
and Tp cultures. (B) Tp cultures give rise to 
more Alcian blue–stained cartilage nodules 
than WL cultures, and exogenous 10 ng/ml 
BMP4 stimulates cartilage formation in both 
cultures. (C) Beads (indicated by arrowheads) 
containing BMP4 (B4) or vehicle (V) stimulates 
expression of EGFP in 24 h cultured limb buds 
from E11.5 Col2-EGFP mice. (D) Quantitative 
RT-PCR demonstrates that the addition of 
BMP4 (20 ng/ml) increases Sox9 expression 
in Tp cultures. (E) Consistent with the increase 
in Sox9 expression, the activity of a SOX9- 
responsive reporter also increases in a 
dose-  dependent fashion with increasing con-
centrations of BMP4 in WL and Tp cultures. 
Error bars represent the SD. *, P < 0.05; 
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and Matn3) met the fi  ltering conditions at both time points. 
Surprisingly, at 24 h, BMP2, -7, and GDF5 (Fig. 2 B, green) are 
down-regulated in response to BMP4, whereas Noggin expres-
sion increases approximately fi  vefold at this time point, as well 
as at the 72-h time point. Although BMPs have been shown to 
induce the expression of the inhibitory Smads, the expression 
of Smad6 and -7 appears unchanged over time and with BMP4 
treatment (confi   rmed using Western blotting; unpublished 
data). However, it is particularly notable that multiple compo-
nents of the retinoid signaling pathway are substantially down-
regulated after BMP4 exposure. Indeed, Aldh1a2 and Cyp26a1, 
which are genes encoding enzymes involved in the synthesis 
and degradation of all-trans RA (atRA), respectively, exhibit 
the largest decreases at 24 h (14.8- and 7.3-fold, respectively). 
Interestingly, other RA synthesis enzymes, Aldh1a1 and 
  Aldh1a3, are unaffected by BMP4 addition. The expression of 
retinol and RA-binding proteins, Rbp1 and Crabp2, and the 
RA-responsive receptor Rarb are also observed to be substan-
tially decreased at 24 and 72 h after BMP addition. Thus, it 
  appears that increased BMP4 signaling causes a wholesale 
  reduction in the expression of multiple constituents of the reti-
noid signaling pathway.
Figure 2.  Elucidation of the genetic programs 
underlying BMP action. (A) Expression proﬁ  l-
ing of BMP4-treated cultures reveals consider-
able changes in several gene families. Genes 
exhibiting a minimal fourfold change in ex-
pression between any of the time points or 
treatments were clustered using the Gene  Trafﬁ  c 
hierarchical clustering algorithm. Genes rep-
resentative of the prominent clusters are shown 
to the right. Blue, red, and green colored 
genes represent ECM genes, retinoid signaling, 
and BMPs and their antagonists, respectively. 
(B) The dataset in A was ﬁ   ltered to identify 
those genes that exhibit a fourfold or greater 
difference in expression between untreated 
and the corresponding treated group. The 
same coloring scheme was applied as in A, 
and the boxed genes represent the four genes 
that exhibited a fourfold change in expression 
at both the 24- and 72-h time points.JCB • VOLUME 174 • NUMBER 1 • 2006  104
RA status infl  uences the expression of many of its bind-
ing proteins, receptors, and catabolism enzymes (de The et al., 
1989; Durand et al., 1992; White et al., 1996). Thus, it is not 
entirely surprising that decreased expression of Aldh1a2 may 
lead to widespread changes in the expression of these genes. 
Consistent with this, changes in Aldh1a2 expression precede 
changes in the expression of these genes (unpublished data). 
For these reasons, we focused our attention on the analysis of 
Aldh1a2 expression in response to BMP4. Quantitative PCR 
confi   rmed that BMP4 addition reduces Aldh1a2 expression 
at 24 h ( 12-fold reduction); further analysis revealed that 
  Aldh1a2 expression is substantially reduced as early as 6 h 
(an approximately sixfold reduction), and at 12 h there is an 
 38-fold differential between treated and untreated cultures 
(Fig. 3 A). As discussed earlier, BMP has the potential to re-
cruit cells with low chondrogenic potential to the chondrocytic 
lineage. Based on this information, we sought to determine 
the distribution of Aldh1a2-expressing cells within limb mes-
enchymal cultures. Whole-mount in situ hybridization re-
vealed that in WL cultures, Aldh1a2 is expressed in discrete 
foci in a pattern reminiscent of Col2a1 expression (Fig. 3 B). 
  Furthermore, addition of BMP4 abolishes Aldh1a2 expression, 
whereas, consistent with previous observations, Col2a1 ex-
pression is intensifi  ed and its domain of expression expanded 
(Fig. 3 B). Thus, it appears that BMP4 expands cartilage for-
mation through down-regulation of Aldh1a2.
BMPs function predominantly through modulation of 
Smad 1, 5, and 8 activity, and through activation of the p38 
MAPK signaling pathway. To gain insights into the mechanisms 
underlying BMP regulation of Aldh1a2, a series of experiments 
were performed to address the requirement for protein synthesis 
and the role of mRNA stability in this process. 20 ng/ml BMP4 
was added either shortly after culture initiation (2 h) or during 
the peak of Aldh1a2 expression ( 18 h), and Aldh1a2 transcript 
abundance was quantifi  ed thereafter at 4 h intervals for 12 h. 
To determine if BMP4 decreased Aldh1a2 mRNA stability, BMP4-
treated and untreated cultures were incubated with 5 μg/ml of the 
transcription inhibitor actinomycin D. In the presence of actino-
mycin D, Aldh1a2 mRNA levels decline in control cultures, and
the presence of BMP4 does not accelerate this decline (Fig. 3 C). 
Figure 3. BMP4 decreases Aldh1a2 ex-
pression and this requires protein synthesis. 
(A) Addition of BMP4 to WL cultures leads to 
an immediate and sustained decrease in tran-
scripts of Aldh1a2, as determined by quanti-
tative PCR (normalized to rRNA expression). 
The numbers above the bars represent the 
ratio of control over treated RNA. Error bars 
represent the SD. (B) Analysis of Aldh1a2 
and Col2a1 in WL cultures via in situ hybrid-
ization. In untreated cultures, Aldh1a2 and 
Col2a1 are expressed in foci. Exogenous 
BMP4 leads to a loss of Aldh1a2 expression, 
and increased and more extensive expres-
sion of Col2a1. Bar, 0.3 mm. (C) Inhibition 
of protein synthesis with 10 μg/ml cyclohexi-
mide (Chx) interferes with BMP4-mediated re-
duction of Aldh1a2. BMP4 does not modify 
Aldh1a2 mRNA stability as determined by 
measurement of Aldh1a2 mRNA abundance 
after inhibition of transcription with actinomy-
cin-D (5 ug/ml). 20 ng/ml BMP4 was added 
at either 2 or 18 h after culture initiation (top 
and bottom, respectively). #, P < 0.001.BMP SIGNALING ATTENUATES RETINOID SIGNALING • HOFFMAN ET AL. 105
In contrast, treatment of cultures with the protein synthesis 
  inhibitor cycloheximide abolished down-regulation of Aldh1a2 
by BMP4 (Fig. 3 C). There is an initial slight downward trend 
in the BMP4 and cycloheximide-treated cultures at the 4-h time 
point, but by 8 and 12 h there is no signifi  cant difference be-
tween the cycloheximide-treated control and BMP4 cultures. 
Thus, down-regulation of Aldh1a2 by BMP4 requires protein 
synthesis, indicating that BMP4 probably acts indirectly through 
the regulation of factors to down-regulate Aldh1a2.
Endogenous RA signaling regulates 
expression of the chondroblast phenotype
To further demonstrate the potential importance of ALDH1a2 
in BMP4 action, we fi  rst examined the role of endogenous RA 
synthesis and degradation in chondrogenesis. Catabolic inactiva-
tion of RA is mediated by the CYP26 subfamily of cytochrome 
P450 enzymes (Niederreither et al., 2002a). Inhibition of RA 
degradation with an inhibitor of cytochrome P450 enzymes, 
ketoconazole (Osanai and Petkovich, 2005), leads to increased 
endogenous RA signaling, as evaluated with an RA-responsive 
reporter gene. Under these conditions, even small changes in 
endogenous RA availability (approximately fourfold) lead to a 
>10-fold reduction in SOX9 activity and a decrease in the for-
mation of cartilage nodules (Fig. 4 A, insets). Importantly, the 
effects of ketoconazole on the retinoid and SOX9-responsive 
reporter genes can be completely reversed through addition of 
a pan-RAR antagonist, demonstrating that the observed effects 
of ketoconazole in this system reside in its ability to inhibit 
CYP26 enzyme activity (Fig. 4 B). Conversely, RA degradation 
increases through heterologous expression of Cyp26a1, and this 
is accompanied by a decrease in RA response element (RARE) 
reporter gene activity and an approximately fourfold increase in 
SOX9 activity (Fig. 4 C). Consistent with these observations, 
inhibition of ALDH1a2 activity with the ALDH1 inhibitor 
DEAB (Perz-Edwards et al., 2001) results in an approximately 
sevenfold reduction in “RA availability” and an approximately 
fi  vefold increase in SOX9 activity; this is associated with in-
creased cartilage nodule formation (Fig. 4 D, insets). To follow 
Col2a1 expression in live cultures, WL cultures were estab-
lished from transgenic embryos that contain a 6.3-kb portion of 
the Col2a1 promoter, driving expression of EGFP (Grant et al., 
2000). In control cultures, weak transgene expression is appar-
ent within 24 h, and by 96 h an abundance of EGFP-positive 
nodules can be observed (Fig. 4 E). Modulation of endogenous 
Figure 4.  Modulation of endogenous retinoid signaling impacts SOX9 activity and cartilage formation. (A) Inhibition of CYP26 activity in WL cultures with 
ketoconazole (added at day 0) leads to an increase in retinoid signaling, as measured with a retinoid-responsive reporter gene (RARE-luc). Conversely, this 
treatment leads to a dose-dependent decrease in SOX9 activity, as determined with the SOX9-responsive reporter pGL3(4X48), as well as decreased carti-
lage formation (insets). (B) The effects of ketoconazole on SOX9 activity can be efﬁ  ciently rescued by the addition of a pan-RAR antagonist (310). (C) Over-
expression of Cyp26a1 decreases endogenous retinoid levels and increases SOX9 activity. (D) Attenuation of ALDH activity with DEAB (added at day 0) 
decreases retinoid levels (pG5 + Bind-DEF), increases SOX9 activity, and increases cartilage formation (insets). (E) Ketoconazole and DEAB treatments 
(both added at day 0) lead to substantive changes in the expression of a Col2 transgene in WL cultures; ketoconazole treatment leads to fewer and smaller 
EGFP-positive nodules. In contrast, DEAB causes precocious expression of the transgene (24 h) and expansion of EGFP-positive cells. Under these   conditions, 
EGFP cells no longer appear in well-deﬁ   ned nodules, but are distributed throughout the cultures. Error bars represent the SD. #, P < 0.001. 
Bars: (A) 0.5 mm; (D) 1 mm; (E) 0.25 mm.JCB • VOLUME 174 • NUMBER 1 • 2006  106
retinoid signaling via treatment with ketoconazole signifi  cantly 
impacts transgene expression, with fewer EGFP-positive cells 
being evident in these cultures. In contrast, attenuation of RA 
synthesis with DEAB leads to precocious and widespread trans-
gene expression in comparison to control cultures (Fig. 4 E). 
Together, these results demonstrate that small changes in en-
dogenous retinoid status profoundly infl  uence expression of the 
chondroblast phenotype.
BMP4 action is potentiated 
by and requires RAR-mediated repression
We have previously shown in transgenic mice that cells ex-
pressing a weak, constitutively active Rara1 transgene pre-
sent with skeletal abnormalities; of particular interest was 
the fi  nding that transgene-expressing cells are generally ab-
sent from cartilages (Cash et al., 1997; Weston et al., 2000). 
Moreover, the addition of BMP2 or -4 fails to rescue the chon-
drogenic defect within the transgenic mesenchyme, leading to 
the postulation that the BMP signaling pathway operates up-
stream or in parallel to the retinoid signaling pathway within 
the chondrogenic program (Weston et al., 2000). To further 
delineate this relationship, we examined the ability of BMP4 
signaling to modulate retinoid signaling directly. The addition 
of BMP4 to WL cultures leads to a dose-dependent decrease 
in RARE reporter gene activity, correlating with an increase 
in SOX9 activity (Fig. 5 A). In previous studies, we demon-
strated that expression of the chondroblast phenotype relies 
on RAR-mediated repression (Weston et al., 2002). RAR-
mediated repression involves recruitment of nuclear-corepressor 
complexes to target genes (Weston et al., 2003a). As such, 
we hypothesized that if BMP4 functions through the attenu-
ation of retinoid signaling, then the chondrogenic-stimulatory 
Figure 5.  The prochondrogenic activity of BMP4 
involves the attenuation of retinoid signaling and 
is enhanced by RAR-mediated gene repression. 
(A) Increasing concentrations of BMP4 (added at 
day 0) lead to a dose-dependent decrease in reti-
noid signaling (pG5 + Bind-RAR[DEF]) and an in-
crease in SOX9 activity (pGL3[4X48]). (B) The 
ability of 10 ng/ml BMP4 to stimulate SOX9 activ-
ity (pGL3[4X48]) and decrease retinoid signaling 
(RARE-luc) is enhanced by coexpression of RARα 
and/or its nuclear corepressor NCOR2. (C) Expres-
sion of the type I BMPRs (Bmpr1a or Bmpr1b) in the 
presence and absence of BMP4 also increases 
SOX9 activity and reduces retinoid signaling. 
(D and E) The addition of 100 nM atRA effectively 
neutralizes the stimulatory effect of BMP4 on both 
SOX9 activity (D) and cartilage formation (E). 
(F) Inhibition of atRA degradation by ketoconazole 
only partially interferes with BMP4-induced SOX9 
activity. 10 ng/ml BMP4 was added at T = 0 (day 
0; D0) and 2 uM ketoconazole was added at D0 
or day 1 (D1). With the exception of B and C, in 
all experiments, cultures were treated 1 h after 
transfection; in B and C, cells were treated 24 h 
after transfection. Error bars represent the SD. 
**, P < 0.01; #, P < 0.001. Bar, 0.3 mm.BMP SIGNALING ATTENUATES RETINOID SIGNALING • HOFFMAN ET AL. 107
action of BMP4 will be potentiated by the presence of NCOR2 
and/or RARα. Indeed, heterologous expression of Ncor2 or 
Ncor2 and Rara together increases SOX9 activity by  2- and 
10-fold, respectively. Treatment with BMP4 alone leads to a 
3.6-fold increase in reporter gene activity, whereas treatment 
with BMP4 combined with expression of Ncor2 or Ncor2 
and Rara increases reporter activity by 10- and 30-fold, re-
spectively (Fig. 5 B). Importantly, SOX9 activity correlates 
inversely with the extent of the decrease in RARE reporter 
activity (Fig. 5 B). Consistent with our observations, overex-
pression of either of the BMP receptor (Bmpr) type I receptors, 
a or b, stimulates SOX9 activity, and this is associated with a 
reduction in RARE-luc activity (Fig. 5 C). These effects are 
potentiated by BMP4 addition. Together, these observations 
suggest that down-regulation of retinoid signaling in primary 
limb mesenchymal cells favors expression of a chondrogenic 
cell fate. Furthermore, addition of 100 nM atRA completely 
abrogates the prochondrogenic effects of BMP4 on the afore-
mentioned reporter genes and on cartilage nodule formation 
(Fig. 5, C and D). Interestingly, treatment with ketoconazole 
on either day 0 or 1 of culture also inhibits the prochondro-
genic action of BMP4 (Fig. 5 F), again indicating that even 
small changes in endogenous retinoid signaling affect expres-
sion of the chondrogenic phenotype.
Figure 6.  BMPs and GDFs with prochondrogenic 
  activity abrogate retinoid signaling. (A) The BMPs and 
GDFs increase cartilage formation to varying extents, 
as determined by staining of 4-d WL cultures with 
Alcian blue. (B) WL cultures transfected with reporter 
genes responsive to SOX9 activity (pGL3[4X48]) or 
retinoid signaling status [RARE-luc; pG5 + pBIND-
RAR(DEF)], exhibit increased and decreased activity, 
respectively, to BMP2 (B2), 4 (B4), 6 (B6), and 7 (B7) 
and GDF5 (G5). All proteins were added at 10 ng/ml, 
with the exception of GDF5, which was added at 
50 ng/ml; atRA and 310 were supplemented to a 
  ﬁ   nal concentration of 100 nM. (C) Aldh1a2 and 
Cyp26a1 expression is inversely proportional to 
SOX9 activity as determined by qPCR. (D) Antago-
nism of retinoid signaling phenocopies the effects 
of BMP4. WL cultures derived from Col2-transgenic 
mice were treated with vehicle, 20 ng/ml BMP4, or 
100 nM of a pan-RAR antagonist (310). Note the more 
extensive network of EGFP-positive cells in the treated 
cultures. Images were collected 48 h after   culture 
  initiation. Error bars represent the SD. *, P < 0.05; 
#, P < 0.001. Bars: (A) 1 mm; (D) 0.25 mm.JCB • VOLUME 174 • NUMBER 1 • 2006  108
Several of the BMPs and GDFs exhibit chondrogenic 
stimulatory activity; thus, we were interested in determining 
whether these factors also infl  uence retinoid signaling. As il-
lustrated in Fig. 6 A, the addition of BMP2, -4, -6, -7, or GDF5 
stimulates chondrogenesis to varying extents. All of these fac-
tors are also expressed in the developing limb at various times 
during the formation of skeletal elements. Consistent with their 
effects on cartilage nodule formation, these ligands also exhibit 
a similar activity in their ability to increase SOX9 reporter gene 
expression (Fig. 6 B). Under these conditions, each factor also 
attenuates retinoid signaling, with BMP4 and GDF5 exhibit-
ing the greatest negative effect (Fig. 6 B). Indeed, quantitative 
PCR further demonstrates that each factor decreases expres-
sion of both Aldh1a2 and Cyp26a1 (Fig. 6 C). The promoter of 
Cyp26a1 is retinoid-responsive (Loudig et al., 2000) and, thus, 
its decreased expression under these conditions provides fur-
ther support that the presence of the aforementioned BMP/GDF 
  abrogates retinoid signaling.
As indicated earlier, the addition of BMP4 leads to wide-
spread cartilage formation both in vitro and in vivo. Enhanced 
cartilage formation after BMP4 treatment can also be observed 
within WL cultures derived from Col2-EGFP transgenic mice 
where BMP4 expression leads to widespread transgene 
  expression. If BMPs operate, at least in part, through attenua-
tion of retinoid signaling, then it would be expected that inhi-
bition of retinoid signaling would phenocopy the action of 
BMPs. This is indeed the case; treatment of transgenic-derived 
WL cultures with either a pan-RAR antagonist or the ALDH1 
inhibitor DEAB, albeit to a lesser extent, also leads to wide-
spread transgene expression in a pattern reminiscent of BMP4 
(Fig. 6 D). Collectively, these experiments suggest that the 
prochondrogenic activity of many of the BMPs and GDFs 
  resides in their ability to abrogate expression of Aldh1a2, con-
sequently resulting in the reduced activation of the retinoid 
signaling pathway.
RA availability is regulated by BMP 
signaling in vitro and in vivo
In the forelimb, the autopod cartilages, as determined by 
Col2a1 expression, fi   rst become evident around early E11, 
with the hindlimb following  0.5 d later (Fig. 7 A). At the be-
ginning of autopod development, Col2a1 expression in precar-
tilaginous digital rays is quite weak, but quickly intensifi  es, 
such that by late E12 all the digits exhibit strong Col2a1 
  expression. In contrast, Aldh1a2 exhibits a dynamic pattern of 
expression that quickly changes from a band of expression 
through the early autopod to a fragmented appearance a few 
hours later (Fig. 7 A). Bifurcation of Aldh1a2 expression in the 
autopod occurs over a relatively short period of time ( 9 h) 
and is closely associated with digit formation. As previously 
reported, Aldh1a2 expression appears between the developing 
zeugopodal elements, within the regions fl  anking the digit car-
tilages, and within the interdigital region (IDR; Niederreither 
et al., 1997).
To assess the ability of BMP4 to regulate Aldh1a2 expres-
sion in limb buds, Affi  -Gel blue beads soaked in either vehicle 
or 20 ng/μl BMP4 were implanted into the IDR region of late 
Figure 7.  Aldh1a2 and Col2a1 exhibit dynamic, but distinct, expression 
patterns during zeugopod and autopod formation, and BMP4 down-
  regulates  Aldh1a2 expression in the developing autopod. (A) At the 
  beginning of E11, Col2a1 expression is evident in the developing zeugo-
pod, with very weak expression evident in the autopod of the forelimb 
and hindlimb. During E11 in the forelimb, Col2a1 becomes abundantly 
expressed in the autopod, and by late E11, Col2a1 appears strongly 
with the hindlimb autopod (upper top right). Aldh1a2 is expressed be-
tween the developing zeugopods (white arrowheads) and in a band 
throughout the presumptive autopod (black arrowheads). During a 6–8 h 
period in the forelimb and hindlimb (top series in both images), Aldh1a2 
expression in the autopod becomes fragmented (arrow) eventually local-
izing to regions that ﬂ  ank the developing digits. (B) Introduction of beads 
soaked in vehicle (−) had no apparent effect on EGFP expression (white 
arrowheads) in limb buds derived from Col2-EGFP forelimbs, whereas 
beads soaked with 20 ng/μl BMP4 stimulated EGFP expression (white 
arrowheads). (C) BMP containing Afﬁ   -Gel blue beads (blue) down-
  regulates Aldh1a2 in the same limb buds as measured by whole-mount 
in situ hybridization. Beads soaked in either vehicle or BMP4 were 
  implanted into the IDR of  E11.75 forelimb buds, and limbs were visual-
ized and ﬁ  xed after 24 h of culture. In the control limbs, all beads (white 
arrowheads) were associated with various amounts of Aldh1a2 expres-
sion and no ectopic EGFP expression (B and C). Ectopic EGFP expression 
was observed around all BMP4-containing beads, and this was accompa-
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E11 limb buds, followed by 24 h of organ culture. Implantation 
of BMP4-soaked beads into limb organ cultures stimulates ec-
topic Col2-EGFP expression (Fig. 7 B) and substantially modi-
fi  es Aldh1a2 expression (Fig. 7 C). Consistent with the ability 
of BMP4 to stimulate ectopic cartilage in the early IDR as re-
ported by others, BMP-soaked beads stimulated EGFP expres-
sion around the bead of all implanted limb buds (n = 10). EGFP 
expression was not detected around control beads (n  = 8). 
Aldh1a2 was expressed to varying levels around control beads. 
In contrast, Aldh1a2 expression was excluded from those 
  regions around the BMP4-soaked beads (Fig. 7 C). Together, 
these results demonstrate that BMP4 down-regulates the 
expression of Aldh1a2 in limb buds.
During early appendicular skeletal development, the 
BMPs, GDFs, and their receptors exhibit a complex pattern 
of expression, appearing at various times and locations within 
the cartilaginous anlagens. In this regard, activated BMP 
  signaling has been observed in the developing cartilages, and 
an absence of the Bmpr1a and -1b severely compromises pre-
cartilaginous condensation formation and chondroblast dif-
ferentiation (Yoon et al., 2005). Activation of either of these 
two receptors leads to a stage-dependent increase in cartilage 
formation (Zou et al., 1997). In contrast, activated retinoid 
signaling inhibits chondrogenesis, whereas decreased reti-
noid signaling, either through antagonism of the receptors 
or in compound Rar knockouts, promotes chondrogenesis 
in vitro and in vivo (Zou et al., 1997; Weston et al., 2003a,b). 
Together, these observations would suggest that Aldh1a2 
and liganded Rars should be excluded from developing 
cartilages. To examine the relationship of Aldh1a2-expressing 
cells and developing cartilages, double in situ hybridization 
was used in vitro and in vivo in WL cultures and E11.25–12.5 
embryos, respectively. Aldh1a2 and Col2a1 are expressed 
in spatially distinct regions (Fig. 8, A and B). More specifi  -
cally, Aldh1a2-expressing cells are excluded from Col2a1-
expressing regions and from the apical ectodermal ridge and 
subjacent mesenchyme. During autopod development, small 
rays of Col2a1-expressing cells can be observed to bisect 
the band of Aldh1a2 expression (Fig. 8 A). Consistent with 
these observations, Aldh1a2-expressing cells are excluded from 
Col2a1-expressing regions in WL cultures. Furthermore, the 
distribution of   Aldh1a2-positive cells would be expected to 
cause localized activation of the retinoid signaling pathway. 
This is, indeed, the case because establishment of WL   cultures 
from a transgenic mouse harboring an RA-responsive reporter 
gene (RARE-hsp68-lacZ; Rossant et al., 1991) demonstrates 
foci of transgene-expressing cells, which are distinct from 
the developing cartilages (Fig. 8 C). Transgene expression is 
markedly increased and decreased in response to 50 or 100 nM 
of exogenous atRA or the addition of 100 nM of 310, respec-
tively (unpublished data). In both culture systems, BMP4 
leads to expansion of Col2a1-expressing cells and increased 
cartilage formation, as well as substantial reduction in Aldh1a2 
expression and RARE activity (Fig. 8 B, C). In aggregate, 
these fi  ndings suggest that during autopod development BMP 
signaling regulates expression of the chondrogenic phenotype 
by controlling RA availability.
Discussion
Manipulation of either the BMP or the retinoid signaling path-
way severely compromises skeletal ontogenesis. Although the 
mechanism of action of BMPs in chondrogenesis is poorly 
 defi  ned, previous studies have implied a potential connection 
between the BMP and RA pathways (Weston et al., 2000).   
Using an unbiased genome-wide expression profi  ling   strategy, we 
have defi  ned the precise nature of this relationship and demon-
strate, both in cell and organ culture, that BMP signaling controls 
RA availability by regulating Aldh1a2 expression.  Furthermore, 
Figure 8.  Aldh1a2-expressing cells are distinct from Col2a1-expressing 
cells in vitro and in vivo. (A) Aldh1a2-expressing cells (red staining) are 
excluded from Col2a1-positive (brown staining) regions as determined by 
double whole-mount in situ hybridization. During autopod development, 
Aldh1a2 expression is progressively extinguished in those regions that 
  begin to express Col2a1. In the bottom image, Aldh1a2 expression is 
  sub  divided by the developing digits (black arrowheads) and Aldh1a2 
expression is expressed between the developing zeugopod elements 
(white arrowhead). (B) Similar to what was observed in vivo, double in situ 
hybridization of Aldh1a2 (purple) and Col2a1 (orange) of day 1 WL 
  cultures reveals that Aldh1a2-expressing cells are excluded from Col2a1-
expressing regions. Addition of BMP4, however, leads to extensive Col2a1 
expression and loss of Aldh1a2 expression. (C) Similarly, WL cultures 
  established from RARE-LacZ reporter mice exhibit foci of transgene-
  expressing cells (purple-stained cells) after 3 d of culture, which are distinct 
from Alcian blue–stained regions. Further, addition of 20 ng/ml BMP4 
abolishes expression of the transgene. Bars: (B and C, left) 0.15 mm; 
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unliganded Rars and RAR-mediated repression support expres-
sion of the chondrogenic phenotype. Thus, BMP signaling pro-
motes chondrogenesis by enhancing RAR-  mediated repression, 
which itself is regulated via attenuation of RA availability.
Function of BMP signaling 
in chondrogenesis: involvement 
of the retinoid signaling pathway
BMP2, -4 and -7, along with GDF5, bind and activate the BMPR 
type I a and b receptors. Several hallmarks of activated BMP/
GDF signaling are observed in the developing skeleton, includ-
ing the phosphorylation of Smads (1, 5, or 8; Brunet et al., 1998; 
Yoon et al., 2005). Noggin is also often up-regulated in response 
to the activation of BMPRIs (Canalis et al., 2003); this, too, was 
observed in this study (Fig. 2). An essential requirement for 
BMPRI-mediated signaling in endochondral ossifi  cation has 
been elegantly demonstrated by Yoon et al. (2005) through gen-
eration of compound null mutants of Bmpr1a and -1b. In this 
study, mutant animals were found to exhibit severe defi  ciencies 
in cartilage formation. More specifi  cally, these animals present 
with poorly defi  ned precartilaginous condensations that weakly 
express Sox9. Similarly, excess Noggin in vitro or in vivo leads 
to reduced cartilage formation, and decreased Sox9 expression 
and activity (Pizette and Niswander, 2000; Weston et al., 2000; 
unpublished data). Reduced activity of BMPs or GDFs through 
targeted or spontaneous mutations also negatively impacts the 
formation of precartilaginous condensations and subsequent 
cartilage formation. In contrast, expression of wild-type (Fig. 5 C) 
or constitutively active versions of the BMPR type I receptors 
promotes chondrogenesis (Zou et al., 1997; unpublished data). 
Furthermore, ectopic BMP signaling in vivo and in vitro 
expands cartilage formation, likely through recruitment of cells 
not destined to become chondrocytes (Duprez et al., 1996a,b). 
Thus, BMP signaling appears to act at multiple stages within 
the chondrogenic program, including the establishment, main-
tenance, and differentiation of chondroprogenitors. The ability 
of BMPs to stimulate chondroblast differentiation is infl  uenced 
by retinoid signaling (Figs. 4, 5, and 6), suggesting that at least 
a subset of these activities involves BMP-mediated attenuation 
of the retinoid signaling pathway.
Cells throughout the early autopod exhibit high chondro-
genic potential, and these cells can be directed under a variety 
of conditions to form cartilage in vitro and in vivo (Lee et al., 
1994; Ganan et al., 1996; Rodriguez-Leon et al., 1999). As au-
topod development ensues, the chondrogenic potential of many 
of these cells is lost, especially those within the IDRs, i.e., pre-
chondrogenic mesenchyme loses its ability to become cartilage 
or is inhibited from doing so. In the presence of BMP signals, 
however, these cells express a chondrogenic fate (Fig. 7 A); this 
is especially apparent in the Noggin-null mice, which present 
with very broad digits and greatly limited IDR (Brunet et al., 
1998). Importantly, during the establishment of these distinct 
regions, Aldh1a2 is dynamically expressed within these domains. 
Before overt chondrogenesis and robust expression of Col2a1, 
Aldh1a2 appears as a broad band throughout the autopod. 
As digit formation proceeds, Aldh1a2 expression is quickly 
  extinguished in cartilage-forming regions, becoming localized 
to the nonchondrogenic fl  anking regions. At this embryonic 
stage, the developing limb is exquisitely sensitive to changes in 
retinoid status (Weston et al., 2003b), and the presence of 
  Aldh1a2 is congruent with a role for retinoid signaling in inhibit-
ing expression of the chondrogenic phenotype in cells fl  anking 
the developing digits. Moreover, activation of a RA-responsive 
reporter in transgenic mice can be observed within the early 
IDR (Rossant et al., 1991), and RARE-expressing cells are 
  excluded from developing cartilages (Fig. 8 C). In contrast, 
  numerous studies have demonstrated that diminished retinoid 
signaling promotes chondrogenesis in vitro and in vivo (Weston 
et al., 2003a,b). In this study, we show that manipulation of en-
dogenous RA production and signaling signifi  cantly impacts 
chondrogenesis (Figs. 4 and 5). In aggregate, these results sug-
gest dual roles for the RARs in regulating chondrogenesis. 
  Unliganded receptors promote expression of the chondroblastic 
phenotype, whereas liganded receptors inhibit differentiation of 
prechondrogenic cells. In this regard, local activation of the ret-
inoid signaling pathway in the developing autopod would spec-
ify nonchondrogenic regions. Consequently, under conditions 
where retinoid signaling is diminished in the developing auto-
pod, widened phalanges and/or cartilage formation in the IDR 
would be expected. Interestingly, Rara/g double-null mice pre-
sent with both of these phenotypes. More specifi  cally, a bulbous 
phalange abnormality is consistently observed, along with 
a less frequent appearance of ectopic cartilages in the IDRs 
  (Lohnes et al., 1994). These mice also exhibit ectopic cartilage 
at several extraskeletal sites (Lohnes et al., 1994; Mendelsohn 
et al., 1994).
Parallels in axial and appendicular 
skeletogenesis: overlapping players 
involving different mechanisms
In the axial skeleton, BMPs play a role in the establishment and 
maintenance of an autoregulatory loop between the transcrip-
tional repressor NKX3.2 and SOX9, thereby promoting axial 
chondrogenesis (Zeng et al., 2002). Interestingly, even though 
BMPs are suffi  cient and necessary for axial and appendicular 
chondrogenesis, their regulation of Sox9 appears to operate 
through an NKX3.2-independent manner in appendicular skel-
etogenesis (Zeng et al., 2002). In axial chondrogenesis, expres-
sion of a chondrogenic fate in somitic mesoderm appears 
to involve derepression of Sox9 by NKX3.2-mediated down-
regulation of gene X, which is a transcriptional repressor of 
Sox9. Likewise, the retinoid pathway appears to be operating in 
a similar manner in the appendicular skeleton to regulate Sox9 
and expression of a chondrogenic fate. In this scenario, activa-
tion of the retinoid signaling pathway up-regulates the expres-
sion of a negative regulator of Sox9 expression, gene Y, leading 
to decreased Sox9 expression and reduced cartilage formation. 
Conversely, antagonism of RAR-mediated signaling down-
  regulates the expression of Y, leading to derepression of 
Sox9 and increased cartilage formation, and, thus, supporting 
a chondrogenic-permissive condition. Thus, at least in the limb, 
BMPs function by attenuating the expression of Aldh1a2, thereby 
stimulating Sox9 expression and activity, and the elaboration of 
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on negative regulators of Sox9, genes X and Y. Further compli-
cating an understanding of BMP action in the limb is that BMPs 
do not appear to act directly to regulate Aldh1a2 expression, as 
protein synthesis is required for this activity. Thus, BMPs pos-
sibly act to increase the expression of a negative regulator of 
  Aldh1a2 expression, or rather that BMPs may act directly 
through a relatively labile protein. Evidence for this latter sce-
nario comes from the observation that in the absence of protein 
synthesis (Fig. 3 C), BMP4 addition leads to an initial transient 
decrease in Aldh1a2 expression. Collectively, these fi  ndings 
demonstrate that BMP4-mediated establishment and mainte-
nance of Sox9 expression in limb chondrogenesis involves 
a cascade of factors with the retinoid signaling pathway fi  guring 
prominently in this program. Further elucidation of the factors 
operating upstream and downstream of the RA signaling 
  pathway will provide additional important insights into the 
  molecular mechanisms underlying the chondrogenic program.
Materials and methods
Reagents
atRA, ketoconazole, diethyl aminobenzaldehyde (DEAB), cycloheximide, 
and actinomycin-D were obtained from Sigma-Aldrich; all compounds 
were dissolved in 95% ethanol, with the exception of ketoconazole, which 
was dissolved in deionized water. BMPs and GDFs were purchased from 
R&D Systems and resuspended according to the manufacturer’s instructions. 
BMPs were added to media at a concentration of 10–20 ng/ml, whereas 
GDF5 was used at a concentration of 50 ng/ml to reﬂ  ect its much lower 
activity (R&D Systems). AGN194310 was provided by R. Chandraratna 
  (Vitae Pharmaceuticals, Irvine, CA).
Plasmid constructs
Reporter plasmids containing SOX9 binding sites (pGL3[4X48]) or trimer-
ized RARE-luc were previously described (Weston et al., 2002). pG5, 
which is a reporter that contains ﬁ  ve GAL4 binding domains, was obtained 
from Promega. To generate GAL4–RAR(DEF) fusions, the C-terminal region 
of Rara encompassing the ligand-binding domain was subcloned in-frame 
into pBIND (Promega). For expression in primary cells, full-length versions 
of murine Cyp26a1 (provided by M. Snead, University of California, Los 
Angeles, Los Angeles, CA) and Rara1 were subcloned into a modiﬁ  ed 
pSG5 (Weston et al., 2002), and the construct containing an N-terminal 
EGFP fusion to full-length Ncor2 (provided by M. Privalsky, University of 
California, Davis, Davis, CA) was as previously described (Goodson et al., 
2005). Mammalian expression plasmids containing BMPR1a and Bmpr1b 
were provided by J. Wrana (University of Toronto, Toronto, Canada).
Establishment and transfection of primary mesenchymal cultures
Primary mesenchymal cultures from CD-1 E11.5 mouse limb buds were es-
tablished as previously described (Weston et al., 2000) with the following 
modiﬁ  cations. For microarray analyses and other speciﬁ  ed experiments, 
distal limb bud tips (subridge region) were dissected from E11.5 mouse 
embryos (the morning of the plug was considered E0.5) as described by 
Gay and Kosher (1984), with the excised region extending 0.3–0.4 mm 
from the distal apex of the limb to the proximal cut edge. After proteolytic 
digestion, cells were ﬁ  ltered through a cell strainer (40 μM; BD Biosci-
ences) to obtain a single cell suspension. Cells were pelleted and resus-
pended at a density of 2 × 10
7/ml and 12–15 10-μl aliquots of this 
suspension were plated into a 35-mm tissue culture dish (Nunc) and 
  allowed to adhere for 1 h. After this period, 2 ml of culture medium consist-
ing of 60% F12/40% DME and supplemented with 10% FBS (Qualiﬁ  ed; 
Invitrogen) was added to each well with or without 20 ng/ml BMP4 (R&D 
Systems); this time was considered T = 0. Cultures were maintained for a 
period of up to 3 d; to minimize handling, culture media was replaced on 
alternate days. Cultures from either RARE-hsp68-lacZ (CD-1 background; 
provided by J. Greer, University of Alberta, Edmonton, CA) or Col2-EGFP 
mice (CD-1 background; derived from breeding of heterozygous trans-
genic males with CD-1 females) were established in a similar manner. 
Alcian blue staining, β-galactosidase staining, and the establishment and 
transient transfection of cultures derived from WL buds was performed as 
described in Weston et al. (2000, 2002). In brief, cultures were trans-
fected at day 0 and extracts for luciferase analysis were collected at day 2 
unless indicated otherwise. For experiments involving primary limb mesen-
chymal cells alone or cells transfected with reporter genes only, factors or 
compounds were added at the time of media addition (T = 0). For experi-
ments involving cotransfection with expression plasmids, factors and com-
pounds were added 24 h after transfection.
Limb bud organ culture and bead implantation
WL buds were collected in PSA from  E11.5 Col2-EGFP embryos. Afﬁ  -Gel 
blue beads (Bio-Rad Laboratories) soaked in either vehicle or BMP4 
(20 ng/μl) for 2 h were transferred into the IDR of the limb buds. Limb buds 
were cultured on Nucleopore Track-Etch membranes (Whatman) at the 
air–liquid interface on top of stainless steel mesh in 12-well tissue culture 
plates. PSA was aspirated from each well and replaced with BGJb medium 
(Invitrogen) containing 10% FBS and antibiotics. The level of culture me-
dium should not exceed the height of the membranes. Limbs were incu-
bated under standard tissue culture conditions. After a 24-h incubation, 
EGFP expression was visualized using a dissection microscope (model 
MZ12; Leica) with epiﬂ  uorescence. Limbs were subsequently ﬁ  xed in 4% 
PFA before processing for whole-mount in situ hybridization.
Transcriptional proﬁ  ling with microarrays: experimental design 
and analysis
RNA was harvested from primary cultures using RNAeasy (QIAGEN) ac-
cording to the manufacturer’s instructions. For the zero time point, cells 
were allowed to attach for 1 h and were subsequently processed for RNA 
isolation. For other cultures, the media was gently aspirated, and any 
  remaining media was blotted from the well before the addition of the lysis 
reagent. After isolation, the RNA was precipitated, and resuspended at 
2 μg/ml; RNA quality was examined on a Bioanalyzer 2100 (Agilent), and 
the expression of Sox9 and Col2a1 were measured using real-time PCR.
For each time point, a minimum of two biological replicates were 
analyzed on U74V2 chips A and B. 10 μg of RNA was labeled and 
  hybridized to the chips using the manufacturer’s recommended protocol. 
Gene expression proﬁ   les were subsequently analyzed using MAS 5.0 
  (Affymetrix) and GeneTrafﬁ  c UNO bioinformatics programs (Stratagene). 
All datasets were initially ﬁ   ltered to remove genes called absent by 
MAS 5.0, and were further ﬁ  ltered as indicated in the text using GeneTrafﬁ  c. 
  Hierarchical clustering was performed in GeneTrafﬁ  c using gene clustering 
and a Pearson correlation distance metric.
Real-time PCR and whole-mount in situ hybridizations
To follow the expression of transcripts for Aldh1a2, Cyp26a1, Col2a1, 
and Sox9, quantitative real-time PCR was performed using the 7900HT 
Sequence Detection System (Applied Biosystems). Primers and MGB probes 
(TaqMan) were designed using PrimerDesigner 2.0 (Applied Biosystems). 
The primer/probe sets used for detection of Sox9 and Col2a1 were as 
described in Weston et al. (2002) and the following primer/probe sets 
were used for quantifying Cyp26a1 transcript abundance: forward primer, 
5′-C  T  C  C  A  A  C  C  T  G  C  A  C  G  A  T  T  C  C  T  -3′, reverse primer, 5′-C  G  G  C  T  G  A  A  G-
G  C  C  T  G  C  A  T  -3′, probe 6FAM-5′-C  A  G  C  G  A  A  A  G  A  A  G  G  T  G  -3′-MGBNFQ. 
Aldh1a2 transcripts were detected using the forward primer, 5′-G  G  T  A  T  C  C  T  C-
C  G  C  A  A  T  G  C  A  A  -3′, reverse primer, 5′-G  C  G  C  A  T  T  T  A  A  G  G  C  A  T  T  G  T  A  A  C  A  -3′,
and probe, 6FAM-5′-C  T  G  G  G  A  C  A  G  T  T  T  G  G  A  T  C  -3′-MGBNFQ. Primer 
and probe concentrations were optimized according to the manufacturer’s 
  instructions. Total RNA was isolated from primary cultures as described above. 
Quantiﬁ  cation was performed using  25 ng of total RNA and the  expression 
of all genes relative to endogenous rRNA was determined using TaqMan 
Ribosomal Control Reagents (Applied Biosystems) and the comparative 
CT method as described in User Bulletin #2 (Applied Biosystems).
Whole-mount in situ hybridization was performed on primary mes-
enchymal cultures as previously described (Weston et al., 2000) with the 
following modiﬁ  cations. After permeabilization using 10 μg/ml proteinase 
K in PBS supplemented with 0.05% Triton X-100, cells were postﬁ  xed in 
4% PFA and 2% glutaraldehyde in PBS. Blocking and antibody incubations 
were performed in 1% blocking reagent (Roche) in 1× maleic acid buffer 
(100 mM maleic acid and 150 mM NaCl, pH 7.5). Riboprobes were syn-
thesized in the presence of UTP-digoxigenin with the appropriate RNA 
polymerase and linearized template DNA, according to manufacturer’s in-
structions (Roche). Riboprobe complementary to Col2a1 was generated 
from BamHI-linearized pBluescript containing 1.1 kb of the C-propeptide–
encoding region of Col2, and transcribed in vitro with T7 RNA polymerase. 
Aldh1a2 riboprobe was transcribed from EcoRI-linearized modiﬁ  ed pBlue-
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  using T3 RNA polymerase. Double in situ hybridizations were performed 
as above, but with the following modiﬁ   cations. Hybridization was per-
formed using both DIG- and ﬂ   uorescein-labeled RNA probes. Cultures 
were subsequently incubated overnight in ﬂ  uorescein-labeled  antibody 
(for detection of Aldh1a2). After incubation in NBT/BCIP/10% PVA–staining 
buffer, cultures were rinsed twice with PBS, and then ﬁ  xed for 10 h in a 4% 
PFA/PBS solution. Cultures were again brieﬂ  y rinsed twice in PBS, and the 
blocking antibody and staining steps were repeated, using an anti–DIG-AP 
antibody and INT/BCIP for detection of Col2a1.
Single and double whole-mount in situ hybridization on limb buds 
and cultured limbs was performed as described by Hargrave and 
  Koopman (2000). Double in situ hybridizations were performed as de-
scribed in the previous paragraph, except that BCIP alone was used for 
detection of Col2a1. To enhance visualization of the light blue (BCIP) and 
purple staining (NBT/BCIP), all images were adjusted to maximum hue in 
Photoshop (Adobe).
Microscopy and image acquisition
Images of ﬁ  xed cultures (in 70% ethanol or Tris-buffered salt solution with 
0.1% Triton X-100 [TBTX]) were collected at room temperature using either 
a dissection microscope (Stemi SV11 Apo, S1.6× objective; Carl Zeiss 
MicroImaging, Inc.) or an inverted microscope (Axiovert S100; Carl Zeiss 
MicroImaging, Inc.) ﬁ  tted with a CP-Achromat 5×, 0.12 NA, CP-Achromat 
10×, 0.25 NA, LD Achrostigmat, 0.55 NA, 10× Fluar, 0.5 NA, and an 
LD Achroplan 40×, 0.6 NA. Monochromatic and color images were ac-
quired from a QImaging Retiga Exi (12-bit) and a QImaging Retiga 1300i 
(12-bit) camera, respectively, using Openlab 4 software (Improvision). Live 
cell and organ culture images were collected at room temperature in cul-
ture media with either an Axiovert S100 microscope or a dissection micro-
scope (MZ FLIII; Plan 1.0× objective; Leica). Photoshop was used to adjust 
some image levels.
Statistical analysis
All luciferase assays were performed in quadruplicate and repeated using 
three distinct preparations of primary cells. Real-time PCR analysis was 
performed in duplicate and repeated a minimum of two times with inde-
pendent RNA samples. Real-time PCR and luciferase reporter data were 
analyzed by one-way analysis of variance, followed by a Bonferroni post-
test for multiple comparisons using GraphPad Prism, Version 4.0 (Graph-
Pad Software, Inc.). Signiﬁ  cance is represented as follows: *, P < 0.05; 
**, P < 0.01; #, P < 0.001. One representative experiment is shown for 
all luciferase and real-time PCR results.
We would like to thank Rosh Chandraratna for providing us with the pan-RAR 
antagonist, AGN 194310. Also, we thank Martin Privalsky for an expression 
plasmid for Ncor2, Malcolm Snead for a full-length version of Cyp26a1, Jeff 
Wrana for Bmpr1a and 1b expression plasmids, London Regional Genomics 
Centre for carrying out the microarray experiments (Jian Wang and David 
Carter), John Greer for the RARE-hsp68-lacZ mice, El Linney for helpful discus-
sions, and D. Alan Underhill for critical review of the manuscript.
L.M. Hoffman and K. Karamboulas were supported by a postdoctoral 
and doctoral fellowship, respectively, from the Canadian Arthritis Network. 
K. Garcha was supported by a doctoral fellowship from the Stem Cell Network. 
L.M. Hoffman was supported by a postdoctoral fellowship from the Canadian 
Arthritis Network, and this research was funded by grants to T.M. Underhill 
from the Canadian Institutes of Health Research (CIHR) and the Canadian 
  Arthritis Network. T.M Underhill holds a New Investigator award from the 
CIHR and The Arthritis Society.
Submitted: 25 April 2006
Accepted: 30 May 2006
References
Abu-Abed, S., P. Dolle, D. Metzger, B. Beckett, P. Chambon, and M. Petkovich. 
2001. The retinoic acid-metabolizing enzyme, CYP26A1, is essential 
for normal hindbrain patterning, vertebral identity, and development of 
posterior structures. Genes Dev. 15:226–240.
Akiyama, H., M.C. Chaboissier, J.F. Martin, A. Schedl, and B. de Crombrugghe. 
2002. The transcription factor Sox9 has essential roles in successive steps 
of the chondrocyte differentiation pathway and is required for expression 
of Sox5 and Sox6. Genes Dev. 16:2813–2828.
Bi, W., J.M. Deng, Z. Zhang, R.R. Behringer, and B. de Crombrugghe. 1999. 
Sox9 is required for cartilage formation. Nat. Genet. 22:85–89.
Brunet, L.J., J.A. McMahon, A.P. McMahon, and R.M. Harland. 1998. Noggin, 
cartilage morphogenesis, and joint formation in the mammalian skeleton. 
Science. 280:1455–1457.
Canalis, E., A.N. Economides, and E. Gazzerro. 2003. Bone morphogenetic pro-
teins, their antagonists, and the skeleton. Endocr. Rev. 24:218–235.
Cash, D.E., C.B. Bock, K. Schughart, E. Linney, and T.M. Underhill. 1997. 
Retinoic acid receptor alpha function in vertebrate limb skeletogenesis: 
a modulator of chondrogenesis. J. Cell Biol. 136:445–457.
de The, H., A. Marchio, P. Tiollais, and A. Dejean. 1989. Differential expression 
and ligand regulation of the retinoic acid receptor alpha and beta genes. 
EMBO J. 8:429–433.
Duprez, D., E.J. Bell, M.K. Richardson, C.W. Archer, L. Wolpert, P.M. Brickell, 
and P.H. Francis-West. 1996a. Overexpression of BMP-2 and BMP-4 
  alters the size and shape of developing skeletal elements in the chick limb. 
Mech. Dev. 57:145–157.
Duprez, D.M., M. Coltey, H. Amthor, P.M. Brickell, and C. Tickle. 1996b. 
Bone morphogenetic protein-2 (BMP-2) inhibits muscle development 
and promotes cartilage formation in chick limb bud cultures. Dev. Biol. 
174:448–452.
Durand, B., M. Saunders, P. Leroy, M. Leid, and P. Chambon. 1992. All-trans 
and 9-cis retinoic acid induction of CRABPII transcription is mediated by 
RAR-RXR heterodimers bound to DR1 and DR2 repeated motifs. Cell. 
71:73–85.
Ganan, Y., D. Macias, M. Duterque-Coquillaud, M.A. Ros, and J.M. Hurle. 1996. 
Role of TGF beta s and BMPs as signals controlling the position of the 
digits and the areas of interdigital cell death in the developing chick limb 
autopod. Development. 122:2349–2357.
Gay, S.W., and R.A. Kosher. 1984. Uniform cartilage differentiation in micro-
mass cultures prepared from a relatively homogeneous population of 
chondrogenic progenitor cells of the chick limb bud: effect of prostaglandins. 
J. Exp. Zool. 232:317–326.
Goodson, M.L., B.A. Jonas, and M.L. Privalsky. 2005. Alternative mRNA splic-
ing of SMRT creates functional diversity by generating corepressor 
isoforms with different affi  nities for different nuclear receptors. J. Biol. 
Chem. 280:7493–7503.
Grant, T.D., J. Cho, K.S. Ariail, N.B. Weksler, R.W. Smith, and W.A. Horton. 
2000. Col2-GFP reporter marks chondrocyte lineage and chondrogenesis 
during mouse skeletal development. Dev. Dyn. 218:394–400.
Hall, B.K., and T. Miyake. 2000. All for one and one for all: condensations and 
the initiation of skeletal development. Bioessays. 22:138–147.
Hargrave, M., and P. Koopman. 2000. In situ hybridization of whole-mount 
 embryos.  Methods Mol. Biol. 123:279–289.
Kingsley, D.M. 2001. Genetic control of bone and joint formation. Novartis 
Found. Symp. 232:213–222.
Lee, K.K., F.C. Li, W.T. Yung, J.L. Kung, J.L. Ng, and K.S. Cheah. 1994. 
Infl  uence of digits, ectoderm, and retinoic acid on chondrogenesis by 
mouse interdigital mesoderm in culture. Dev. Dyn. 201:297–309.
Lohnes, D., M. Mark, C. Mendelsohn, P. Dolle, A. Dierich, P. Gorry, A. 
Gansmuller, and P. Chambon. 1994. Function of the retinoic acid recep-
tors (RARs) during development (I) Craniofacial and skeletal abnormali-
ties in RAR double mutants. Development. 120:2723–2748.
Loudig, O., C. Babichuk, J. White, S. Abu-Abed, C. Mueller, and M. Petkovich. 
2000. Cytochrome P450RAI(CYP26) promoter: a distinct composite reti-
noic acid response element underlies the complex regulation of retinoic 
acid metabolism. Mol. Endocrinol. 14:1483–1497.
Mendelsohn, C., D. Lohnes, D. Decimo, T. Lufkin, M. LeMeur, P. Chambon, and 
M. Mark. 1994. Function of the retinoic acid receptors (RARs) during de-
velopment (II) Multiple abnormalities at various stages of organogenesis 
in RAR double mutants. Development. 120:2749–2771.
Niederreither, K., P. McCaffery, U.C. Drager, P. Chambon, and P. Dolle. 1997. 
Restricted expression and retinoic acid-induced downregulation of the 
retinaldehyde dehydrogenase type 2 (RALDH-2) gene during mouse 
 development.  Mech. Dev. 62:67–78.
Niederreither, K., S. Abu-Abed, B. Schuhbaur, M. Petkovich, P. Chambon, and 
P. Dolle. 2002a. Genetic evidence that oxidative derivatives of retinoic 
acid are not involved in retinoid signaling during mouse development. 
Nat. Genet. 31:84–88.
Niederreither, K., J. Vermot, B. Schuhbaur, P. Chambon, and P. Dolle. 
2002b. Embryonic retinoic acid synthesis is required for forelimb 
growth and anteroposterior patterning in the mouse. Development. 
129:3563–3574.
Osanai, M., and M. Petkovich. 2005. Expression of the retinoic acid-metabolizing
enzyme CYP26A1 limits programmed cell death. Mol. Pharmacol. 
67:1808–1817.
Perz-Edwards, A., N.L. Hardison, and E. Linney. 2001. Retinoic acid-
  mediated gene expression in transgenic reporter zebrafi  sh. Dev. Biol. 
229:89–101.BMP SIGNALING ATTENUATES RETINOID SIGNALING • HOFFMAN ET AL. 113
Pizette, S., and L. Niswander. 2000. BMPs are required at two steps of limb 
chondrogenesis: formation of prechondrogenic condensations and their 
differentiation into chondrocytes. Dev. Biol. 219:237–249.
Robledo, R.F., L. Rajan, X. Li, and T. Lufkin. 2002. The Dlx5 and Dlx6 homeo-
box genes are essential for craniofacial, axial, and appendicular skeletal 
development. Genes Dev. 16:1089–1101.
Rodriguez-Leon, J., R. Merino, D. Macias, Y. Ganan, E. Santesteban, and J.M. 
Hurle. 1999. Retinoic acid regulates programmed cell death through 
BMP signalling. Nat. Cell Biol. 1:125–126.
Rossant, J., R. Zirngibl, D. Cado, M. Shago, and V. Giguere. 1991. Expression 
of a retinoic acid response element-hsplacZ transgene defi  nes specifi  c 
domains of transcriptional activity during mouse embryogenesis. Genes 
Dev. 5:1333–1344.
Smits, P., P. Li, J. Mandel, Z. Zhang, J.M. Deng, R.R. Behringer, B. de 
Crombrugghe, and V. Lefebvre. 2001. The transcription factors L-Sox5 
and Sox6 are essential for cartilage formation. Dev. Cell. 1:277–290.
Weston, A.D., V. Rosen, R.A. Chandraratna, and T.M. Underhill. 2000. 
Regulation of skeletal progenitor differentiation by the BMP and retinoid 
signaling pathways. J. Cell Biol. 148:679–690.
Weston, A.D., R.A. Chandraratna, J. Torchia, and T.M. Underhill. 2002. 
Requirement for RAR-mediated gene repression in skeletal progenitor 
differentiation. J. Cell Biol. 158:39–51.
Weston, A.D., B. Blumberg, and T.M. Underhill. 2003a. Active repression by 
unliganded retinoid receptors in development: less is sometimes more. 
J. Cell Biol. 161:223–228.
Weston, A.D., L.M. Hoffman, and T.M. Underhill. 2003b. Revisiting the role of 
retinoid signaling in skeletal development. Birth Defects Res C Embryo 
Today. 69:156–173.
Weston, A.D., A.V. Sampaio, A.G. Ridgeway, and T.M. Underhill. 2003c. 
Inhibition of p38 MAPK signaling promotes late stages of myogenesis. 
J. Cell Sci. 116:2885–2893.
White, J.A., Y.D. Guo, K. Baetz, B. Beckett-Jones, J. Bonasoro, K.E. Hsu, F.J. 
Dilworth, G. Jones, and M. Petkovich. 1996. Identifi  cation of the reti-
noic acid-inducible all-trans-retinoic acid 4-hydroxylase. J. Biol. Chem. 
271:29922–29927.
Yashiro, K., X. Zhao, M. Uehara, K. Yamashita, M. Nishijima, J. Nishino, Y. 
Saijoh, Y. Sakai, and H. Hamada. 2004. Regulation of retinoic acid dis-
tribution is required for proximodistal patterning and outgrowth of the 
developing mouse limb. Dev. Cell. 6:411–422.
Yoon, B.S., D.A. Ovchinnikov, I. Yoshii, Y. Mishina, R.R. Behringer, and K.M. 
Lyons. 2005. Bmpr1a and Bmpr1b have overlapping functions and 
are essential for chondrogenesis in vivo. Proc. Natl. Acad. Sci. USA. 
102:5062–5067.
Zeng, L., H. Kempf, L.C. Murtaugh, M.E. Sato, and A.B. Lassar. 2002. Shh es-
tablishes an Nkx3.2/Sox9 autoregulatory loop that is maintained by BMP 
signals to induce somitic chondrogenesis. Genes Dev. 16:1990–2005.
Zou, H., R. Wieser, J. Massague, and L. Niswander. 1997. Distinct roles of type 
I bone morphogenetic protein receptors in the formation and differentia-
tion of cartilage. Genes Dev. 11:2191–2203.